MRNA vs TOL · rev $145.0M vs P/E 11, rev $7.34B
Moderna Inc (MRNA) versus Toll Brothers Inc (TOL) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ.
Toll Brothers Inc (TOL) is a residential construction company listed on NYSE.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported TOL revenue for 2026-07-31 was $7.34B. Net income was $751.7M. Revenue was up 56.8% from 2026-04-30 to 2026-07-31. TOL currently screens at market cap $13.99B and trailing P/E 11.4.
MRNA currently screens at market cap $24.52B. TOL currently screens at market cap $13.99B and trailing P/E 11.4.
Not investment advice. Open the MRNA and TOL stock pages for the full models.
Not investment advice.